TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011
TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987